Hepatobiliary: Clinical Trials

Showing 15 trials
Title Investigator
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea, MD
A Phase I/II Study of Gemcitabine, Cisplatin, and MEK162 as Initial Treatment for Advanced Bile Duct or Gallbladder Cancer
[Protocol 13-004]
Lowery, Maeve, MD
A Phase I/II Study of M402 in Combination with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-078]
O'Reilly, Eileen, MD
A Phase IB Study of Onartuzumab Given with Sorafenib in Patients with Advanced Liver Cancer
[Protocol 13-155]
Abou-Alfa, Ghassan, MD
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-211]
Abou-Alfa, Ghassan, MD
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
[Protocol 13-066]
Jarnagin, William, MD
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259]
Abou-Alfa, Ghassan, MD
A Phase III Study of ADI-PEG20/Supportive Care or Placebo/Supportive Care in Patients with Advanced Liver Cancer
[Protocol 11-081]
Abou-Alfa, Ghassan, MD
A Phase III Study of Cabozantinib versus Placebo in Patients with Liver Cancer Who Received Previous Therapy with Sorafenib
[Protocol 13-151]
Abou-Alfa, Ghassan, MD
A Phase III Study of Sorafenib Alone versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Patients with Liver Cancer
[Protocol 13-250]
Goodman, Karyn, MD
A Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039]
Abou-Alfa, Ghassan, MD
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083]
Goodman, Karyn, MD
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102]
Kurtz, Robert, MD
Treatment of Children with All Stages of Hepatoblastoma
[Protocol 10-046]
Kobos, Rachel, MD
Two Phase II Studies of Veliparib for Pancreatic Cancer with a BRCA or PALB2 Mutation: Gemcitabine...
[Protocol 12-045]
O'Reilly, Eileen, MD